Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 122

    1.

    Viral dynamics of HIV: implications for drug development and therapeutic strategies.

    Havlir DV, Richman DD.

    Ann Intern Med. 1996 Jun 1;124(11):984-94. Review.PMID: 8624066 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    HIV therapeutics.

    Richman DD.

    Science. 1996 Jun 28;272(5270):1886-8. No abstract available. PMID: 8658159 [PubMed - indexed for MEDLINE]Related articles

    3.

    Molecular biological assessment methods and understanding the course of the HIV infection.

    Katzenstein TL.

    APMIS Suppl. 2003;(114):1-37. Review.PMID: 14626050 [PubMed - indexed for MEDLINE]Related articles

    4.

    HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.

    Coffin JM.

    Science. 1995 Jan 27;267(5197):483-9.PMID: 7824947 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

    Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Sáag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA.

    JAMA. 1996 Jul 10;276(2):146-54. Review.PMID: 8656507 [PubMed - indexed for MEDLINE]Related articles

    6.

    Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

    Van Vaerenbergh K.

    Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.PMID: 11813503 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antiretroviral therapy in human immunodeficiency virus-infected individuals.

    Spooner KM.

    Adv Intern Med. 1998;43:373-402. Review. No abstract available. PMID: 9506188 [PubMed - indexed for MEDLINE]Related articles

    8.

    Therapeutic interventions in primary HIV infection.

    Kinloch-de Loës S, Perrin L.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S69-76. Review. No abstract available. PMID: 8595514 [PubMed - indexed for MEDLINE]Related articles

    9.

    The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy.

    Havlir DV, Richman DD.

    Springer Semin Immunopathol. 1997;18(3):267-83. Review. No abstract available. PMID: 9089949 [PubMed - indexed for MEDLINE]Related articles

    10.

    HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

    Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D.

    JAMA. 2001 Jul 11;286(2):196-207.PMID: 11448283 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    AIDS pathogenesis: from models to viral dynamics in patients.

    Nowak MA.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S1-5. Review.PMID: 8595501 [PubMed - indexed for MEDLINE]Related articles

    12.

    Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.

    Cohen OJ, Pantaleo G, Lam GK, Fauci AS.

    Springer Semin Immunopathol. 1997;18(3):305-22. Review.PMID: 9089951 [PubMed - indexed for MEDLINE]Related articles

    13.

    HIV chemotherapy.

    Richman DD.

    Nature. 2001 Apr 19;410(6831):995-1001. Review.PMID: 11309630 [PubMed - indexed for MEDLINE]Related articles

    14.

    The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.

    Katzenstein DA, Hammer SM, Hughes MD, Gundacker H, Jackson JB, Fiscus S, Rasheed S, Elbeik T, Reichman R, Japour A, Merigan TC, Hirsch MS.

    N Engl J Med. 1996 Oct 10;335(15):1091-8. Erratum in: N Engl J Med 1997 Oct 9;337(15):1097. PMID: 8813039 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Eradication of HIV--hope or hype?

    [No authors listed]

    PI Perspect. 1996 Sep;(No 19):3-6.PMID: 11363905 [PubMed - indexed for MEDLINE]Related articles

    16.

    The human immunodeficiency virus.

    Hardy WD Jr.

    Med Clin North Am. 1996 Nov;80(6):1239-61. Review.PMID: 8941222 [PubMed - indexed for MEDLINE]Related articles

    17.

    Use and access to viral load measure assays: the need for validation.

    Agosto M.

    Update Natl Minor AIDS Counc. 1995 Jul-Aug:7-8.PMID: 11362791 [PubMed - indexed for MEDLINE]Related articles

    18.

    Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.

    Joos B, Trkola A, Fischer M, Kuster H, Rusert P, Leemann C, Böni J, Oxenius A, Price DA, Phillips RE, Wong JK, Hirschel B, Weber R, Günthard HF; Swiss HIV Cohort Study.

    J Virol. 2005 Jul;79(14):9026-37.PMID: 15994796 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    New information on HIV rapid turnover--what does it mean?

    James JS.

    AIDS Treat News. 1995 Jan 20;(No 215):1-4.PMID: 11362214 [PubMed - indexed for MEDLINE]Related articles

    20.

    The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

    Schapiro JM, Winters MA, Stewart F, Efron B, Norris J, Kozal MJ, Merigan TC.

    Ann Intern Med. 1996 Jun 15;124(12):1039-50.PMID: 8633817 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data